Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | FibroGen Begins Phase 3 Trial of Pamrevlumab for IPF |
|
| 2 | Routine Chest Scans Advised for IPF Patients as Lung Cancer Risk... |
|
| 3 | Researchers Ready New Treatment for IPF |
|
| 4 | PDGFA Found to Stimulate Lung Tissue Repair in Aged IPF Mice |
|
| 5 | Preclinical Study Will Probe Potency of Cymerus MSCs |
|
| 6 | MYMD-1 Shows Promise in Reducing Drivers of IPF Inflammation, Fibrosis |
|
| 7 | Gilead, Galapagos halt IPF study in latest stumble for blockbuster alliance |
|
| 8 | Potential IPF Treatment, Found Using AI, May Move Into Trial... |
|
| 9 | Previous: Rare Disease Day Brings Me Hope as a PF Patient |
|
| 10 | ISABELA Phase 3 Program of Ziritaxestat for IPF to Stop, Galapagos Says |
|
| 11 | LUNGguard System Used for 1st Time With IPF Patient's Transplant |
|
| 12 | Previous: FDA Clears Potential IPF Therapy, IM156, for Phase 1 Trial |
|
| 13 | Stem Cell Study Into Lung Repair for IPF, Like Diseases Wins ALA Grant |
|
| 14 | Light at end of decade-long IPF goal if Coug fans match big gift |
|
| 15 | Another blow for Galapagos and Gilead as ziritaxestat fails in Phase I |
|
| 16 | Fitch Affirms International Personal Finance at 'BB-'; Outlook Negative |
|
| 17 | Insilico preps first candidate for IND studies, hoping to launch trial in IPF by end of 2021 |
|
| 18 | Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis |
|
| 19 | IBSA partner IPF to promote powerlifting |
|
| 20 | Fitch Ratings Updates its IPF China Analytical Comparative Tool |
|
| 21 | USA Powerlifting Case Against IPF Moves to Court of Arbitration for Sport |
|
| 22 | The networks of m(6)A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis |
|
| 23 | IPF plots return to growth following 2020 loss |
|
| 24 | IPF: My dad died from disease Katie Price's mum is fighting |
|
| 25 | AdAlta (1AD): Initiation |
|
| 26 | Idiopathic Pulmonary Fibrosis (IPF) Market – The Courier |
|
| 27 | KENNETH VETTERS Obituary |
|
| 28 | New Preclinical Study to Investigate the High Potency of Cymerus™ MSCs |
|
| 29 | WSU launches fundraising challenge to pay for two new athletic buildings |
|
| 30 | Pennsylvania county that rode the fracking wave is now broke |
|
| 31 | US Offshore Wind on Cusp of Tremendous Growth |
|
| 32 | Chinese firm Insilico to test AI-developed drug |
|
| 33 | Concomitant statin therapy yields benefit on IPF progression |
|
| 34 | Using air purification to protect against COVID-19 on campus | MSUToday | Michigan State University |
|
| 35 | Toward a Better Understanding of the IPF Cough |
|
| 36 | [Full text] The Effect of Nintedanib on T-Cell Activation, Subsets and Functions | DDDT |
|
| 37 | Delay from symptom onset to IPF diagnosis often longer than 1 year |
|
| 38 | Roche’s Actemra to rival against BI’s blockbuster drug Ofev |
|
| 39 | MediciNova to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference |
|
| 40 | Earnings Update: Here's Why Analysts Just Lifted Their International Personal Finance plc (LON:IPF) Price Target To UK£1.39 |
|
| 41 | Ofev Costs to Treat PF-ILD Should Be Reimbursed in Canada, Groups Say |
|
| 42 | IPF Negatively Affects Patients' Quality of Life, Review Study Finds |
|
| 43 | Next:Dosing Begins in 2nd Phase 3 Trial of Antibody Treatment for IPF |
|
| 44 | Targeted therapies developed to reduce lung fibrosis |
|
| 45 | Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline |
|
| 46 | Galecto Publishes GB0139 Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Results in European Respiratory Journal, Showing Marked Impact on Several IPF Biomarkers |
|
| 47 | Calprotectin Is Potential Biomarker of IPF Severity, Study Shows |
|
| 48 | Fatigue Weighs on IPF Patients and Tends to Worsen Over Time... |
|
| 49 | New Report shows OSW renewables has potential to be next great industry |
|
| 50 | Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial |
|
| 51 | Mortality Risk Lower for IPF Patients Diagnosed More Recently... |
|
| 52 | Vicore Pharma Holding AB (publ) publishes the year-end report for 2020 |
|
| 53 | Early Start: Strategies to Improve Outcomes in IPF |
|
| 54 | Inhalable Treatment Enhances Regeneration in Lung Fibrosis Model |
|
| 55 | Ofev May Be Less Tolerable Over Long Term in IPF Patients in... |
|
| 56 | Next:Phase 2 Trial of C21, Potential Oral Therapy for IPF, Opens |
|
| 57 | Idiopathic Pulmonary Fibrosis |
|
| 58 | Pandemic hits profits at listed lender | TheBusinessDesk.com |
|
| 59 | [Full text] A Successful Defect Closure After Total Excision of Seborrheic Keratos | IMCRJ |
|
| 60 | Collapsed Lung Can Be Difficult to Treat in IPF, Linked to Poorer... |
|
| 61 | Connecticut developers pair sheep grazing with solar projects |
|
| 62 | Galecto raises $64m to finance EU filing for inhaled IPF drug |
|
| 63 | Algernon Pharmaceuticals Announces 25% Enrollment in its Ifenprodil IPF and Chronic Cough Phase 2 Human Study |
|
| 64 | Comprehensive Report on Plastic Valve Bags Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | Material Motion, IPF, LC Packaging – NeighborWebSJ |
|
| 65 | IPF Risk Genes Linked to AAV in Study, But Not to AAV-associated... |
|
| 66 | Oral co-trimoxazole fails to reduce adverse outcomes in patients with IPF |
|
| 67 | Where to find value in the commercial property sector |
|
| 68 | Powerlifter Josh Greiner Smashed Teen World Records In Training at 17 Years Old |
|
| 69 | Delayed IPF Diagnoses Linked to Heart, Gastro-esophageal Conditions |
|
| 70 | Massachusetts carbon tax proposed for transportation and heating |
|
| 71 | $2.4M NIH Grant Supports Boston Team Creating Cell Model for IPF |
|
| 72 | United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis |
|
| 73 | Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress |
|
| 74 | Next:Treprostinil Earns FDA Orphan Drug Designation for Treating IPF |
|
| 75 | Powerful treatment for IPF stops dangerous scar formation in mouse lungs |
|
| 76 | IRONGATE GROUP – Voluntary Announcement – Acquisition of Industrial Property Acquisition |
|
| 77 | Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil |
|
| 78 | Experimental Peptide Combined With Ofev Reduced IPF Symptoms in Mice |
|
| 79 | Next:IPF Mortality Rates Decreasing in US, New Study Concludes |
|
| 80 | Next:First Patient Enrolls in Study of NAC for Targeted Treatment in IPF |
|
| 81 | Yale, Baylor create atlas of cellular change in lungs with fibrosis |
|
| 82 | FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2 |
|
| 83 | New lungs bring second chance for local senior |
|
| 84 | IPF market to be worth $3.6 billion by 2029, says GlobalData |
|
| 85 | Large Chest Lymph Nodes in IPF Patients Tied in Study to Higher... |
|
| 86 | FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results |
|
| 87 | Phase 2 Trial of NP-120 for IPF Reaches 25% of Enrollment Target |
|
| 88 | IPF Severity, Progression Correlates With Bilirubin Levels, Study Finds |
|
| 89 | Katie Price pays tribute to her terminally ill mum Amy and thanks her for ‘thick skin’ on International Wom |
|
| 90 | Endeavor Raises $62M for New Trials for IPF Therapy Taladegib |
|
| 91 | Study Links IPF With Increased Risk for Several Cancer Types |
|
| 92 | Idiopathic pulmonary fibrosis: Definition, symptoms, and treatment |
|
| 93 | Algernon Begins Screening Patients for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia |
|
| 94 | To Succeed, I Must Share My IPF Identity With Others |
|
| 95 | First Patient Enrolls In PRECISIONS Study For Treatment Of Idiopathic Pulmonary Fibrosis |
|
| 96 | Quality of Life Reduced by IPF Respiratory, Emotional Factors, Study Says |
|
| 97 | CohBar Antifibrotic Peptide in Combination with Nintedanib Shows Enhanced Effects in an Idiopathic Pulmonary Fibrosis Model |
|
| 98 | With eyes on an IPF franchise, Galapagos pushes second candidate into a dose-finding study |
|
| 99 | Phase 2 Trial of Haduvio for Chronic Cough Due to IPF Again... |
|
| 100 | Pamrevlumab May Be More Effective in IPF Than Esbriet and Ofev... |
|